|
Market Closed -
NSE India S.E.
15:05:07 16/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 2,226.70 INR | -1.06% |
|
-2.89% | +9.41% |
| 09-11 | Glenmark Pharmaceuticals Limited Proposes Dividend for the Year Ended 31 March 2026 | CI |
| 09-07 | Acucort wins trademark protection for Zeqmelit in Ukraine | FW |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.06% | -2.89% | -7.61% | -2.63% | +9.41% | +19.43% | +179.11% | +324.29% | +140.75% | 6.62B | ||
| +0.43% | +6.59% | +10.48% | +7.51% | +16.97% | +53.41% | +103.85% | +428.43% | +1,485.76% | 1,120B | ||
| +0.90% | -2.25% | -4.38% | +2.24% | +23.49% | +33.02% | +62.23% | +58.44% | +117.39% | 616B | ||
| +0.71% | +3.24% | +8.73% | +12.20% | +24.92% | +25.81% | +93.86% | +161.06% | +374.36% | 504B | ||
| -0.13% | +5.98% | +4.61% | +14.35% | +15.54% | +32.91% | +50.39% | +5.26% | +60.81% | 367B | ||
| +0.52% | +0.24% | +0.72% | +14.35% | +38.66% | +73.92% | +40.15% | +86.33% | +134.87% | 360B | ||
| -0.95% | +4.70% | +9.12% | +1.17% | +13.78% | +19.51% | +43.00% | +62.10% | +65.38% | 288B | ||
| -1.98% | +3.73% | +2.55% | -1.44% | -9.75% | -0.86% | +13.43% | +41.51% | +151.59% | 258B | ||
| -0.35% | +4.25% | +14.92% | +16.39% | +32.13% | +46.21% | +50.76% | +108.09% | +167.13% | 234B | ||
| -0.75% | +3.32% | +5.76% | +14.59% | +27.25% | +32.53% | +97.21% | +130.95% | +114.69% | 194B | ||
| -1.46% | +1.70% | -4.77% | -22.69% | -20.18% | -29.07% | -63.28% | -21.09% | +91.94% | 173B | ||
| +0.48% | +4.60% | +7.72% | +17.66% | +18.80% | +22.08% | -11.09% | -28.71% | -9.43% | 169B | ||
| -1.77% | -2.03% | -2.63% | +2.82% | +10.23% | +22.30% | +33.62% | +174.93% | +530.75% | 127B | ||
| -1.35% | +1.07% | -6.05% | -1.26% | +10.77% | +37.70% | +4.51% | +2.38% | +20.05% | 122B | ||
| +0.62% | +7.03% | +13.25% | +19.44% | +22.50% | +29.58% | +120.70% | +392.16% | +524.12% | 117B | ||
| -0.32% | +6.43% | -0.16% | -4.78% | +2.08% | +13.98% | +24.73% | +6.46% | -11.89% | 99.56B | ||
| -0.30% | +0.59% | -3.24% | -6.50% | -13.03% | -16.67% | -30.75% | -14.19% | +5.02% | 96.96B | ||
| -7.82% | -3.11% | +49.71% | +245.23% | +639.27% | +703.28% | +137.12% | -32.76% | - | 87.04B | ||
| -0.70% | +5.92% | +2.08% | +16.47% | +2.44% | +38.93% | -6.27% | +42.93% | +112.75% | 78.96B | ||
| +0.73% | +4.68% | +9.57% | +4.60% | +17.70% | +29.01% | -3.38% | -24.98% | +47.94% | 70.58B | ||
| Average | -0.42% | +2.83% | +5.52% | +17.49% | +44.15% | +59.35% | +47.00% | +95.18% | +217.05% | 254.39B | |
| Weighted average by Cap. | -0.04% | +3.55% | +5.70% | +11.09% | +27.70% | +45.25% | +58.87% | +151.26% | +454.68% |
- Stock Market
- Stocks
- GLENMARK Stock
- Sector Glenmark Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
















